Cited by 488Pancreatic function and diabetesAlzheimer's disease research and treatmentsDiabetes Treatment and Management

The DOI matches its Crossref record.

Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.

Kahn, S E, Andrikopoulos, S, Verchere, C B·1999·Diabetes

DOI 10.2337/diabetes.48.2.241

Open this paper in CoChat — free account

Abstract

Islet amyloid has been recognized as a pathological entity in type 2 diabetes since the turn of the century. It has as its unique component the islet beta-cell peptide islet amyloid polypeptide (IAPP), or amylin, which is cosecreted with insulin. In addition to this unique component, islet amyloid contains other proteins, such as apolipoprotein E and the heparan sulfate proteoglycan perlecan, which are typically observed in other forms of generalized and localized amyloid. Islet amyloid is observed at pathological examination in the vast majority of individuals with type 2 diabetes but is rarely observed in humans without disturbances of glucose metabolism. In contrast to IAPP from rodents, human IAPP has been shown to form amyloid fibrils in vitro. Because all human subjects produce and secrete the amyloidogenic form of IAPP, yet not all develop islet amyloid, some other factor(s) must be involved in islet amyloid formation. One hypothesis is that an alteration in beta-cell function resulting in a change in the production, processing, and/or secretion of IAPP is critical to the initial formation of islet amyloid fibrils in human diabetes. This nidus of amyloid fibrils then allows the progressive accumulation of IAPP-containing fibrils and the eventual replacement of beta-cell mass by amyloid and contributes to the development of hyperglycemia. One factor that may be involved in producing the changes in the beta-cell that result in the initiation of amyloid formation is the consumption of increased dietary fat. Dietary fat is known to alter islet beta-cell peptide production, processing, and secretion, and studies in transgenic mice expressing human IAPP support the operation of this mechanism. Further investigation using this and other models should provide insight into the mechanism(s) involved in islet amyloidogenesis and allow the development of therapeutic agents that inhibit or reverse amyloid fibril formation, with the goal being to preserve beta-cell function and improve glucose control in type 2 diabetes.

Integrity signals

Registry

Crossref · 10.2337/diabetes.48.2.241

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Still being checked.

Sorted by citations

Items 301–400 of 488

Amyloid in Human Islets of Langerhans: Immunologic Evidence That Islet Amyloid Polypeptide Is Modified in Amyloidogenesis
Ma, Z., Westermark, P., & Westermark, G. T. (2000) · Pancreas · doi:10.1097/00006676-200008000-00015 · Cited by 16
BACE2 is Stored in Secretory Granules of Mouse and Rat Pancreatic β Cells
Finzi, G., Franzi, F., Placidi, C., Acquati, F., Palumbo, E., Russo, A., Taramelli, R., Sessa, F., & Rosa, S. L. (2008) · Ultrastructural Pathology · doi:10.1080/01913120802486217 · Cited by 16
Aromatic interactions directing peptide nano-assembly
Sasidharan, S., & Ramakrishnan, V. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2022.01.001 · Cited by 16
Exploring Peptido‐Nanocomposites in the Context of Amyloid Diseases
Andrikopoulos, N., Tang, H., Wang, Y., Liang, X., Li, Y., Davis, T. P., & Ke, P. C. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202309958 · Cited by 15
RIPK3 promotes islet amyloid-induced β-cell loss and glucose intolerance in a humanized mouse model of type 2 diabetes
Mukherjee, N., Contreras, C., Li, L., Colglazier, K. A., Mather, E. G., Kalwat, M. A., Esser, N., Kahn, S. E., & Templin, A. T. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101877 · Cited by 15
Self-citation
Inhibitors of islet amyloid polypeptide fibrillogenesis, and the treatment of type-2 diabetes
Scrocchi, L. A., Chen, Y., Wang, F., Han, K. A., Ha, K., Wu, L., & Fraser, P. E. (2003) · International Journal of Peptide Research and Therapeutics · doi:10.1007/bf02442587 · Cited by 15
PROINSULIN, PROAMYLIN AND THE BETA CELL ENDOPLASMIC RETICULUM: THE KEY FOR THE PATHOGENESIS OF DIFFERENT DIABETES PHENOTYPES
Ionescu-Tirgoviste, C., & Guja, C. (2007) · Cited by 15
Sterol Structure Strongly Modulates Membrane–Islet Amyloid Polypeptide Interactions
Zhang, X., London, E., & Raleigh, D. P. (2018) · Biochemistry · doi:10.1021/acs.biochem.7b01190 · Cited by 15
Role of islet peptides in beta cell regulation and type 2 diabetes therapy
Khan, D., Moffet, C. R., Flatt, P. R., & Kelly, C. (2018) · Peptides · doi:10.1016/j.peptides.2017.11.014 · Cited by 15
Enterohepatic Helicobacter species isolated from the ileum, liver and colon of a baboon with pancreatic islet amyloidosis
García, A., Xu, S., Dewhirst, F. E., Nambiar, P. R., & Fox, J. G. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46707-0 · Cited by 15
Metabolic and Molecular Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A., Mandarino, L. J., & Ferrannini, E. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0310 · Cited by 15
Molecular mechanisms for the destabilization of model membranes by islet amyloid polypeptide
Divakara, M. B., Martinez, D., Ravi, A., Veerabhadrappa, B., Ramana, V., Habenstein, B., Loquet, A., & Santosh, M. S. (2018) · Biophysical Chemistry · doi:10.1016/j.bpc.2018.12.002 · Cited by 14
Application of Photochemical Cross-linking to the Study of Oligomerization of Amyloidogenic Proteins
Lopes, D. H. J., Sinha, S., Rosensweig, C., & Bitan, G. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-551-0_2 · Cited by 14
The Mitochondrial Peptidase Pitrilysin Degrades Islet Amyloid Polypeptide in Beta-Cells
Guan, H., Chow, K. M., Song, E.-S., Verma, N., Despa, F., & Hersh, L. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133263 · Cited by 14
ICA512 RESP18 homology domain is a protein-condensing factor and insulin fibrillation inhibitor
Toledo, P. L., Torkko, J. M., Müller, A., Wegbrod, C., Sönmez, A., Solimena, M., & Ermácora, M. R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007607 · Cited by 14
d -Retro Inverso Amylin and the Stability of Amylin Fibrils
Pandey, P., Nguyen, N. N. M., & Hansmann, U. H. E. (2020) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.0c00523 · Cited by 14
Immunohistochemical localization of amylin in human pancreas, thyroid, pituitary and their tumors
Rotondo, F., Vidal, S., Bell, D., Horváth, É., Kovács, K., Scheithauer, B. W., & Lloyd, R. V. (2003) · Acta Histochemica · doi:10.1078/0065-1281-00718 · Cited by 14
Fundamental Structures and Behaviors of Proteins
Laurence, J. S., & Middaugh, C. R. (2010) · Wiley eBooks · doi:10.1002/9780470769829.ch1 · Cited by 14
Plasma C-peptide level is inversely associated with family history of type 2 diabetes in Korean type 2 diabetic patients
Chung, J. O., Cho, D. H., Chung, D. J., & Chung, M. Y. (2010) · Endocrine Journal · doi:10.1507/endocrj.k10e-175 · Cited by 13
Observation(s)
Available, N. A. N. (2001) · Diabetologia · doi:10.1007/s001250100599 · Cited by 13
Simulations of cross-amyloid aggregation of amyloid-β and islet amyloid polypeptide fragments
Kawecki, G., King, K. M., Cramer, N. A., Bevan, D. R., & Brown, A. M. (2022) · Biophysical Journal · doi:10.1016/j.bpj.2022.05.007 · Cited by 14
Evaluation of Amylase Activity in Patients with Type 2 Daibetes Mellitus
Ewadh, M. J. (2014) · American Journal of BioScience · doi:10.11648/j.ajbio.20140205.11 · Cited by 12
Light-driven porphyrin modulating fibrillation of hIAPP20–29 peptide
Yang, G., Liu, L., Wang, J., Bortolini, C., & Dong, M. (2017) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2017.01.089 · Cited by 12
Addition of exogenous sodium palmitate increases the IAPP/insulin mRNA ratio via GPR40 in human EndoC-βH1 cells
Krizhanovskii, C., Fred, R. G., Oskarsson, M. E., Westermark, G. T., & Welsh, N. (2017) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2017.1368745 · Cited by 11
Loss of perlecan heparan sulfate glycosaminoglycans lowers body weight and decreases islet amyloid deposition in human islet amyloid polypeptide transgenic mice
Templin, A. T., Mellati, M., Soininen, R., Hogan, M. F., Esser, N., Castillo, J., Zraika, S., Kahn, S. E., & Hull, R. L. (2019) · Protein Engineering Design and Selection · doi:10.1093/protein/gzz041 · Cited by 12
Self-citation
The pathogenesis of type 2 diabetes mellitus
Chatterjee, M., & Scobie, I. N. (2002) · Practical Diabetes · doi:10.1002/pdi.385 · Cited by 12
Low concentration IL-1β promotes islet amyloid formation by increasing hIAPP release from humanised mouse islets in vitro
Templin, A. T., Mellati, M., Meier, D., Esser, N., Hogan, M. F., Castillo, J. J., Akter, R., Raleigh, D., Zraika, S., Hull, R., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05232-2 · Cited by 11
Self-citation
Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects
Tomita, T. (2011) · Islets · doi:10.4161/isl.3.4.15875 · Cited by 12
Amylin in pancreatic islets and pancreatic endocrine neoplasms
Tomita, T. (2003) · Pathology International · doi:10.1046/j.1440-1827.2003.01532.x · Cited by 12
Practical and Critical Instruction for Nonhuman Primate Diabetic Models
He, S., Wang, D., & Wei, L. (2013) · Transplantation Proceedings · doi:10.1016/j.transproceed.2012.11.027 · Cited by 11
Clinicopathologic characteristics, prevalence, and risk factors of spontaneous diabetes in sooty mangabeys (Cercocebus atys).
Jones, A. C., Herndon, J. G., Courtney, C. L., Collura, L. A., & Cohen, J. K. (2014) · PubMed Central · Cited by 11
Implications of Heparan Sulfate and Heparanase in Amyloid Diseases
Li, J., & Zhang, X. L. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34521-1_25 · Cited by 11
Expression of tmp21 in normal adult human tissues.
Xie, J. B., Yang, Y., Li, J., Hou, J., Xia, K., Song, W., & Liu, S. (2014) · PubMed Central · Cited by 11
Amyloidosis and Amyloid Proteins: Brief History and Definitions
Westermark, P. (2005) · Wiley eBooks · doi:10.1002/9783527619344.ch1 · Cited by 11
Antioxidant Effect of Tyr-Ala Extracted from Zein on INS-1 Cells and Type 2 Diabetes High-Fat-Diet-Induced Mice
Zhai, J., Zhu, Y., Wu, Y. Z., Li, N., Cao, Y., Guo, Y. C., & Xu, L. (2022) · Antioxidants · doi:10.3390/antiox11061111 · Cited by 10
Conformation-reconstructed multivalent antibody mimic for amplified mitigation of human islet amyloid polypeptide amyloidogenesis
Zhao, L., Wang, S., Hu, Q., Jia, H., Xin, Y., Luo, L., & Meng, F. (2022) · Nanoscale · doi:10.1039/d1nr08090c · Cited by 10
Liposome Damage and Modeling of Fragments of Human Islet Amyloid Polypeptide (IAPP) Support a Two-Step Model of Membrane Destruction
Heyl, D., Osborne, J. M., Pamarthy, S., Samisetti, S., Gray, A. W., Jayaprakash, A. D., Konda, S., Brown, D. J., Miller, S. R., Eizadkhah, R., et al. (2010) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-010-9202-3 · Cited by 10
Mutation at position −132 in the islet amyloid polypeptide (IAPP) gene promoter enhances basal transcriptional activity through a new CRE-like binding site
Novials, A., Mato, E., Lucas, M., Franco, C., Rivas, M., Santisteban, P., & Gomis, R. (2004) · Diabetologia · doi:10.1007/s00125-004-1439-y · Cited by 10
Postnatally disturbed pancreatic islet cell distribution in human islet amyloid polypeptide transgenic mice.
Wong, H., Bo, A.-R., Lips, C. J. M., Höppener, J., & Sundler, F. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00298-7 · Cited by 10
Therapeutic Apheresis in Metabolic Syndrome
Воинов, В. А. (2018) · Immunology Endocrine & Metabolic Agents - Medicinal Chemistry · doi:10.2174/1871522218666180608114536 · Cited by 10
Anti‐diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP‐1
Åhrén, B., Adner, N., Svartberg, J. B., Petrella, E. M., Holst, J. J., & Gutniak, M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00657_1.x · Cited by 10
IAPP - oligomerisation levels in plasma of people with type 2 diabetes
Rehn, F., Kraemer‐Schulien, V., Bujnicki, T., Bannach, O., Tschoepe, D., Stratmann, B., & Willbold, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-70255-3 · Cited by 10
Heterogeneous and Surface-Catalyzed Amyloid Aggregation Monitored by Spatially Resolved Fluorescence and Single Molecule Microscopy
Zhou, X., Sinkjær, A. W., Zhang, M., Pinholt, H. D., Nielsen, H. M., Hatzakis, N. S., van de Weert, M., & Foderà, V. (2023) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.2c03400 · Cited by 9
Overall Sulfation of Heparan Sulfate from Pancreatic Islet β-TC3 Cells Increases Maximal Fibril Formation but Does Not Determine Binding to the Amyloidogenic Peptide Islet Amyloid Polypeptide
Hull, R. L., Peters, M. J., Potter‐Perigo, S., Chan, C. K., Wight, T. N., & Kinsella, M. G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.409847 · Cited by 9
Aspects of structural landscape of human islet amyloid polypeptide
He, J., Dai, J., Li, J., Peng, X., & Niemi, A. J. (2015) · The Journal of Chemical Physics · doi:10.1063/1.4905586 · Cited by 8
Distinguishing islet amyloid polypeptide fibril structures with infrared isotope-label spectroscopy
Saxena, V., Steendam, R., & Jansen, T. L. C. (2022) · The Journal of Chemical Physics · doi:10.1063/5.0082322 · Cited by 9
Immunocytochemical staining for islet amyloid polypeptide in pancreatic endocrine tumors
Tomita, T. (2011) · Islets · doi:10.4161/isl.3.6.17866 · Cited by 9
Role of iduronate-2-sulfatase in glucose-stimulated insulin secretion by activation of exocytosis
Piquer, S., Casas, S., Quesada, I., Nadal, Á., Julià, M., Novials, A., & Gomis, R. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90878.2008 · Cited by 9
The Occurrence of Islet Amyloid Polypeptide Amyloidosis in Japanese Subjects
Su, Y., Misumi, Y., Ueda, M., Shono, M., Tasaki, M., Guo, J., Jono, H., Obayashi, K., Senokuchi, T., Yamagata, K., et al. (2012) · Pancreas · doi:10.1097/mpa.0b013e318249926a · Cited by 9
A pilot study of pancreatic islet amyloid PET imaging with [18F]FDDNP
Lu, Z., Xie, J., Yan, R., Yu, Z., Sun, Z., Yu, F., Gong, X., Feng, H., Lü, J., & Zhang, Y. (2018) · Nuclear Medicine Communications · doi:10.1097/mnm.0000000000000849 · Cited by 9
Polyphenolic Gallotannins 1,3,6-Tri-O-galloyl-β- d -glucose and Corilagin Attenuate IAPP Amyloid Formation and Cytotoxicity by Primarily Targeting Secondary Nucleation
Khalifa, J., Sulaimon, R., Côté‐Cyr, M., Nguyen, P. T., Peslherbe, G. H., Bourgault, S., & Gaudreault, R. (2025) · Biochemistry · doi:10.1021/acs.biochem.5c00139 · Cited by 8
The effect of aluminum ion on the aggregation of human islet amyloid polypeptide (11-28)
Su, L.-L., Lu, C., Yan, P., Zhang, N., Cai, S., Zhang, G., Zhou, X., & Li, B. (2017) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmx015 · Cited by 8
Type 2 Diabetes—Effect of Compensatory Oversecretion as a Reason for β‐Cell Collapse
Grill, V., & Björklund, A. (2002) · Journal of Diabetes Research · doi:10.1080/15604280214276 · Cited by 8
Increased secretion and expression of amylin in spontaneously diabetic Goto-Kakizaki rats treated with rhGLP-1 (7–36)
Weng, H., Gu, Q., Liu, M., Cheng, N., Duan, L., & Gao, X. (2008) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2008.00782.x · Cited by 8
Age related changes in pancreatic beta cells: A putative extra-cerebral site of Alzheimer’s pathology
Maj, M. A. (2011) · World Journal of Diabetes · doi:10.4239/wjd.v2.i4.49 · Cited by 9
The effects of chondroitin sulfate and serum albumin on the fibrillation of human islet amyloid polypeptide at phospholipid membranes
Li, Y., Wang, L., Lu, T., Wei, Y., & Li, F. (2016) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp07642k · Cited by 8
Effect of Post-Translational Amidation on Islet Amyloid Polypeptide Conformational Ensemble: Implications for Its Aggregation Early Steps
Tran, L., & Ha‐Duong, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111896 · Cited by 8
Senile amyloidoses – diseases of increasing importance
Enqvist, S., Peng, S., Persson, A., & Westermark, P. (2003) · Acta Histochemica · doi:10.1078/0065-1281-00727 · Cited by 8
Engineering a new β-cell: a critical venture requiring special attention to constantly changing physiological needs
Kahn, S. E. (2004) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2004.02.005 · Cited by 8
Self-citation
Faster Amylin Aggregation on Fibrillar Collagen I Hastens Diabetic Progression through β-Cell Death and Loss of Function
Hazari, M. A., Kannan, G., Dasgupta, S., Pavan, M. K., Jha, A. K., Sultana, F., Pujahari, S. R., Singh, S., Dutta, S., Pydi, S. P., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.4c15698 · Cited by 7
Pancreatic Islet Amyloid and Diabetes
Clark, A., & Moffitt, J. H. (2007) · Springer eBooks · doi:10.1007/978-0-387-36534-3_10 · Cited by 7
Obesity and Type 2 Diabetes
(2012) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/978160805361211201010039 · Cited by 7
Electrostatic Polarization Effect on Cooperative Aggregation of Full Length Human Islet Amyloid
Li, Y., Wang, X., Ren, L., Cao, X., Ji, C., Xia, F., & Zhang, J. Z. H. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00215 · Cited by 7
Role of lysine residue of islet amyloid polypeptide in fibril formation, membrane binding, and inhibitor binding
Wu, M., Chan, A.-C., & Tu, L. (2020) · Biochimie · doi:10.1016/j.biochi.2020.08.012 · Cited by 7
Interplay between human islet amyloid polypeptide aggregates and micro-heterogeneous membranes
Tan, Q., Liu, H., Duan, M., & Huo, S. (2021) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2021.183691 · Cited by 7
Amylin S20G mutation in Mexican population
Garcia-Gonzalez, C. L., Montoya-Fuentes, H., Padilla-Rosas, M., & Sánchez‐Corona, J. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.07.030 · Cited by 7
Probing the Meaning of Persistent Propeptide Release in Type 1 Diabetes
Kahn, S. E., Templin, A. T., Hull, R. L., & Verchere, C. B. (2019) · Diabetes Care · doi:10.2337/dci18-0054 · Cited by 6
Self-citation
High Protein Diet Improves Biochemical and Metabolic Hormonal Profile in Alloxan-Induced Diabetic Rats
Muzaffar, H. (2019) · Pakistan Veterinary Journal · doi:10.29261/pakvetj/2019.016 · Cited by 7
Obesity and Type 2 Diabetes
Zhyzhneuskaya, S. V., & Taylor, R. (2017) · Endocrinology · doi:10.1007/978-3-319-47685-8_21-1 · Cited by 8
Identification of iduronate-2-sulfatase in mouse pancreatic islets
Coronado-Pons, I., Novials, A., Casas, S., Clark, A., & Gomis, R. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00528.2003 · Cited by 7
Zukünftige Angriffspunkte für die Therapie des Typ-2-Diabetes
Stingl, H., & Roden, M. (2004) · Wiener klinische Wochenschrift · doi:10.1007/bf03041051 · Cited by 7
Regulation of Insulin Secretion in Vivo
Vidal, J., & Kahn, S. E. (2001) · Endocrine updates · doi:10.1007/978-1-4615-1597-5_7 · Cited by 7
Self-citation
Prevention of Type 2 Diabetes Mellitus
Simpson, R. W., Tuomilehto, J. O., Lindström, J., Shaw, J. E., & Zimmet, P. (2003) · Wiley eBooks · doi:10.1002/0470862092.d1118 · Cited by 7
Structural and functional insights into interactions of oligomeric (alpha)-synuclein with lipid membranes
Rooijen, V. B. D. (2009) · doi:10.3990/1.9789036529310 · Cited by 7
AggNet : Advancing protein aggregation analysis through deep learning and protein language model
He, W., Xu, X., Li, H., Zhou, J., & Gao, X. (2025) · Protein Science · doi:10.1002/pro.70031 · Cited by 6
Adaptation of pancreatic islet cyto-architecture during development
Striegel, D. A., Hara, M., & Periwal, V. (2016) · Physical Biology · doi:10.1088/1478-3975/13/2/025004 · Cited by 7
Interactions of the N-terminal domain of human islet amyloid polypeptide with lipid membranes: the effect of cholesterol
Li, Y., Guan, L., Lu, T., Li, H., Li, Z., & Li, F. (2016) · RSC Advances · doi:10.1039/c6ra19714k · Cited by 6
Development and evaluation of agents for targeting visceral amyloid.
Wall, J. S., Solomon, A., & Kennel, S. J. (2011) · PubMed · Cited by 6
Hypercytolipidemia-induced cellular lipoapoptosis: Cytostructural and endometabolic basis of progressive organo-involution following expression of diabetes (db/db) and obese (ob/ob) mutation syndromes
Garris, D. R. (2006) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2006.02.002 · Cited by 6
Overview of Fibrillar and Oligomeric Assemblies of Amyloidogenic Proteins
Rahimi, F., & Bitan, G. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_1 · Cited by 6
Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control
Chisalita, S. I., Lindström, T., Jennersjö, P. E. S., Paulsson, J. F., Westermark, G. T., OLSSON, A. G., & Arnqvist, H. J. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0055-6 · Cited by 5
Amylin in human pancreatic islets
Tomita, T. (2003) · Pathology · doi:10.1080/0031302021000062299 · Cited by 6
Explainable AI-based analysis of human pancreas sections identifies traits of type 2 diabetes
Klein, L., Ziegler, S., Gerst, F., Morgenroth, Y., Gotkowski, K., Schöniger, E., Heni, M., Kipke, N., Friedland, D., Seiler, A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69295-2 · Cited by 6
The current state of amyloidosis therapeutics and the potential role of fluorine in their treatment
Dabur, M., Loureiro, J. A., & Pereira, M. D. C. (2022) · Biochimie · doi:10.1016/j.biochi.2022.08.003 · Cited by 6
Visualization of polymorphism in apolipoprotein C-II amyloid fibrils
Teoh, C. L., Yagi, H., Griffin, M. D. W., Goto, Y., & Howlett, G. J. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvq117 · Cited by 5
Hen lysozyme fibrillogenesis, molten globule intermediate and effect of copper salts
Cerón, R., Peimbert, M., Rojo‐Domínguez, A., & Nájera, H. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.2006090 · Cited by 5
Delineating the impact of N21D mutation on the conformational preferences and structural transitions in human islet amyloid polypeptide
Mehta, T., & Goyal, B. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.124528 · Cited by 5
Extended life span is associated with insulin resistance in a transgenic mouse model of insulinoma secreting human islet amyloid polypeptide
Andrikopoulos, S., Hull, R. L., Verchere, C. B., Wang, F., Wilbur, S. M., Wight, T. N., Marzban, L., & Kahn, S. E. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00137.2003 · Cited by 5
Self-citation
Neuroendocrine Control of Energy Stores
Cone, R. D., & Elmquist, J. K. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00035-3 · Cited by 5
Islet Amyloid Polypeptide
Abedini, A., & Raleigh, D. P. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch23 · Cited by 5
Differential Modulation of Copper(II) Interactions with the 18–22 Coordinating Amylin Fragment by the Geometric Isomers of a New Nicotinoyl Hydrazone: A First Study
Carvalho, A., Pougy, K. D. C., Pinheiro, A. S., Cukierman, D. S., & Rey, N. A. (2025) · ACS Omega · doi:10.1021/acsomega.5c04850 · Cited by 4
Luminescent platforms for monitoring changes in the solubility of amylin and huntingtin in living cells
Zhao, J., Vu, Q. V., & Stains, C. I. (2016) · Molecular BioSystems · doi:10.1039/c6mb00454g · Cited by 4
Type 2 Diabetes Mellitus
Hupfeld, C. J., & Olefsky, J. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00040-8 · Cited by 7
On the Role of Islet Amyloid Polypeptide in Glucose Intolerance and Anorexia of Pancreatic Cancer
Herrington, M. K., Arnelo, U., & Permert, J. (2001) · Pancreatology · doi:10.1159/000055822 · Cited by 4
Glycosylphosphatidylinositol‐specific phospholipase D immunoreactivity is present in islet amyloid in type 2 diabetes
Larson, D., Kennedy, M. A., Bowen, R. F., Verchere, C. B., & Deeg, M. (2004) · The Journal of Pathology · doi:10.1002/path.1600 · Cited by 4
Self-citation
THE ROLE OF THE PANCREATIC AMYLOID IN THE PATHOGENESIS OF TYPE 2 DIABETES
Ionescu-Tirgoviste, C., Guja, C., Vasilica, C., & Gutu, D. (2010) · Cited by 4
Biosynthesis, Processing, and Secretion of the Islet Hormones
Steiner, D. F., Rhodes, C. J., Philipson, L. H., Bell, G. I., & Chan, S. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00032-0 · Cited by 4
Oophorectomy promotes islet amyloid formation in human islet amyloid polypeptide transgenic mice.
Hull, R. L., Verchere, C. B., Andrikopoulos, S., Wang, F., Vidal, J., & Kahn, S. E. (2001) · Diabetes · doi:10.2337/diabetes.50.2007.s184 · Cited by 4
Self-citation
Aldolase-regulated G3BP1/2+ condensates control insulin mRNA storage in beta cells
Quezada, E., Knoch, K.-P., Vasiljević, J., Seiler, A., Pal, A., Gunasekaran, A., Münster, C., Friedland, D., Schöniger, E., Sönmez, A., et al. (2025) · The EMBO Journal · doi:10.1038/s44318-025-00448-7 · Cited by 4
Modulation of hIAPP Fibrillation by Rationally Designed Hexapeptides Revealed by Molecular Dynamics and Experimental Investigations
Rani, D., Priyadarshi, N., Singhal, N. K., & Goyal, B. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00269 · Cited by 3

Authors: Kahn, S. E., Andrikopoulos, S., & Verchere, C. B.
Affiliations: University of Washington (US)
ORCID: Kahn, S E
Verchere, C B
Venue: Diabetes
Publisher: American Diabetes Association
Published: 1999-02-01
Volume: 48
Issue: 2
Pages: 241-253
ISSN: 0012-1797 (ISSN-L)
1939-327X
DOI: 10.2337/diabetes.48.2.241
OpenAlex: W1992231742
Cited by: 488
References: 0
Citations by year: 2026: 8 · 2025: 8 · 2024: 9 · 2023: 10 · 2022: 16 · 2021: 11 · 2020: 15 · 2019: 13 · 2018: 24 · 2017: 12 · 2016: 18 · 2015: 17 · 2014: 21 · 2013: 17 · 2012: 25
FWCI: 24.90
Type: journal article
Language: en
Open access: closed
Locations: Diabetes (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Diabetes and Digestive and Kidney Diseases (R01DK050703, DK48152, DK50703, R01DK048152, DK-17047, P30DK017047)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords: islet amyloid, type 2 diabetes, amylin, beta-cell function, amyloid fibril formation, apolipoprotein E, perlecan, dietary fat, hyperglycemia, beta-cell mass loss, amyloidogenesis
MeSH terms: Amyloid, Amyloidosis, Animals, Diabetes Mellitus, Type 2, Dietary Fats, Humans, Islets of Langerhans, Islet Amyloid Polypeptide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks